NASDAQ:FLDM

Fluidigm News Headlines

$7.10
+0.75 (+11.81 %)
(As of 07/28/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.75
$7.22
50-Day Range
$5.45
$7.10
52-Week Range
$3.71
$12.45
Volume4.23 million shs
Average Volume1.85 million shs
Market Capitalization$532.24 million
P/E RatioN/A
Dividend YieldN/A
Beta1.58

Fluidigm (NASDAQ FLDM) News Headlines Today

SourceHeadline
Notable Wednesday Option Activity: TNL, FLDM, LVS - NasdaqNotable Wednesday Option Activity: TNL, FLDM, LVS - Nasdaq
nasdaq.com - July 28 at 6:07 PM
Fluidigm Stock Shoots Higher On Bloomberg Report Of Exploring Potential Sale - Markets InsiderFluidigm Stock Shoots Higher On Bloomberg Report Of Exploring Potential Sale - Markets Insider
markets.businessinsider.com - July 28 at 1:05 PM
Fluidigm (NASDAQ:FLDM) Shares Gap Up to $6.35Fluidigm (NASDAQ:FLDM) Shares Gap Up to $6.35
americanbankingnews.com - July 28 at 11:14 AM
Fluidigm Sees Unusually High Options Volume (NASDAQ:FLDM)Fluidigm Sees Unusually High Options Volume (NASDAQ:FLDM)
americanbankingnews.com - July 28 at 9:41 AM
Medical Technology Firm Fluidigm Is Said to Explore Sale - BloombergMedical Technology Firm Fluidigm Is Said to Explore Sale - Bloomberg
bloomberg.com - July 28 at 12:53 AM
$5.5+ Billion Global Sequencing Reagents Market to 2028 - by Technology, Application, Reagent Type, End-user and Geography - ResearchAndMarkets.com - Business Wire$5.5+ Billion Global Sequencing Reagents Market to 2028 - by Technology, Application, Reagent Type, End-user and Geography - ResearchAndMarkets.com - Business Wire
businesswire.com - July 23 at 9:09 AM
Fluidigm Announces Conference Call and Webcast of Second Quarter 2021 Financial Results - Yahoo FinanceFluidigm Announces Conference Call and Webcast of Second Quarter 2021 Financial Results - Yahoo Finance
finance.yahoo.com - July 9 at 1:03 PM
Fluidigm Announces Conference Call and Webcast of Second Quarter 2021 Financial ResultsFluidigm Announces Conference Call and Webcast of Second Quarter 2021 Financial Results
finance.yahoo.com - July 8 at 7:55 PM
Global Single-cell Analysis Market Size, Share & Trends Analysis Report 2021-2028 - ResearchAndMarkets.com - Yahoo FinanceGlobal Single-cell Analysis Market Size, Share & Trends Analysis Report 2021-2028 - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - June 22 at 7:55 PM
Global Single-cell Analysis Market Size, Share & Trends Analysis Report 2021-2028 - ResearchAndMarkets.com - Business WireGlobal Single-cell Analysis Market Size, Share & Trends Analysis Report 2021-2028 - ResearchAndMarkets.com - Business Wire
businesswire.com - June 22 at 9:53 AM
Fluidigm Corporation: Discounted Life Sciences Instrument Developer Offers Compelling Entry Point - Seeking AlphaFluidigm Corporation: Discounted Life Sciences Instrument Developer Offers Compelling Entry Point - Seeking Alpha
seekingalpha.com - June 20 at 2:38 PM
Rover Labs Provides Saliva-based COVID-19 Testing to New York City Public SchoolsRover Labs Provides Saliva-based COVID-19 Testing to New York City Public Schools
finance.yahoo.com - June 17 at 8:46 AM
Fluidigm Shares Move Higher; Co Tweets Announcing the Advanta™ SARS-CoV-2 Mutation Assay Panel for use with saliva or extracted RNA, a reflex-free and #highthroughput solution to detect CDC and WHO identified #Variants of Concern... - BenzingaFluidigm Shares Move Higher; Co Tweets 'Announcing the Advanta™ SARS-CoV-2 Mutation Assay Panel for use with saliva or extracted RNA, a reflex-free and #highthroughput solution to detect CDC and WHO identified #Variants of Concern...' - Benzinga
benzinga.com - June 9 at 2:52 PM
Next-Generation CyTOF XT Redefines Cytometry with Advances - GlobeNewswireNext-Generation CyTOF XT Redefines Cytometry with Advances - GlobeNewswire
globenewswire.com - May 25 at 6:30 PM
Next-Generation CyTOF XT Redefines Cytometry with Advances in Automation, Throughput, Time to Results and Total Cost of OwnershipNext-Generation CyTOF XT Redefines Cytometry with Advances in Automation, Throughput, Time to Results and Total Cost of Ownership
finance.yahoo.com - May 25 at 6:30 PM
Imaging Mass Cytometry Utilized by Global Consortium Focused on New Precision Medicine Approaches for Treatment of - GlobeNewswireImaging Mass Cytometry Utilized by Global Consortium Focused on New Precision Medicine Approaches for Treatment of - GlobeNewswire
globenewswire.com - May 24 at 9:26 AM
Imaging Mass Cytometry Utilized by Global Consortium Focused on New Precision Medicine Approaches for Treatment of Rheumatoid ArthritisImaging Mass Cytometry Utilized by Global Consortium Focused on New Precision Medicine Approaches for Treatment of Rheumatoid Arthritis
finance.yahoo.com - May 24 at 9:26 AM
Single-cell Analysis Market Size Worth $6.7 Billion By 2028 | CAGR: 15.0%: Grand View Research, Inc. - Yahoo FinanceSingle-cell Analysis Market Size Worth $6.7 Billion By 2028 | CAGR: 15.0%: Grand View Research, Inc. - Yahoo Finance
finance.yahoo.com - May 17 at 2:45 PM
Fluidigm to Present at Upcoming Investor Conferences - GlobeNewswireFluidigm to Present at Upcoming Investor Conferences - GlobeNewswire
globenewswire.com - May 14 at 9:42 AM
Fluidigm to Present at Upcoming Investor ConferencesFluidigm to Present at Upcoming Investor Conferences
finance.yahoo.com - May 14 at 9:42 AM
Fluidigm, ShockWave Medical leads healthcare gainers; Larimar Therapeutics, Nano-X Imaging among major losers - Seeking AlphaFluidigm, ShockWave Medical leads healthcare gainers; Larimar Therapeutics, Nano-X Imaging among major losers - Seeking Alpha
seekingalpha.com - May 11 at 2:07 PM
Fluidigm, ShockWave Medical leads healthcare gainers; Larimar Therapeutics, Nano-X Imaging among major losersFluidigm, ShockWave Medical leads healthcare gainers; Larimar Therapeutics, Nano-X Imaging among major losers
seekingalpha.com - May 11 at 11:12 AM
Caligan takes stake in COVID-19 test maker Fluidigm, may eye changes - ReutersCaligan takes stake in COVID-19 test maker Fluidigm, may eye changes - Reuters
reuters.com - May 11 at 9:06 AM
Fluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern Time - Yahoo FinanceFluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern Time - Yahoo Finance
finance.yahoo.com - May 11 at 9:06 AM
Fluidigm gains after report that activist takes 11% stake, may push for unit sale - Seeking AlphaFluidigm gains after report that activist takes 11% stake, may push for unit sale - Seeking Alpha
seekingalpha.com - May 11 at 1:39 AM
Fluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. - GlobeNewswireFluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. - GlobeNewswire
globenewswire.com - May 10 at 3:38 PM
Fluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern TimeFluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern Time
finance.yahoo.com - May 10 at 3:38 PM
Fluidigm Corporations (FLDM) CEO Chris Linthwaite on Q1 2021 Results - Earnings Call Transcript - Seeking AlphaFluidigm Corporation's (FLDM) CEO Chris Linthwaite on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 9 at 7:06 PM
Data Published in Nature Communications Demonstrate the Power of Fluidigms CyTOF and Imaging Mass Cytometry Technologies - GlobeNewswireData Published in Nature Communications Demonstrate the Power of Fluidigm's CyTOF and Imaging Mass Cytometry Technologies - GlobeNewswire
globenewswire.com - May 8 at 11:59 PM
Data Published in Nature Communications Demonstrate the - GlobeNewswireData Published in Nature Communications Demonstrate the - GlobeNewswire
globenewswire.com - May 6 at 6:04 PM
Fluidigm Corporation (NASDAQ:FLDM) - Fluidigm: Q1 Earnings Insights - BenzingaFluidigm Corporation (NASDAQ:FLDM) - Fluidigm: Q1 Earnings Insights - Benzinga
benzinga.com - May 6 at 6:04 PM
Fluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year Period - GlobeNewswireFluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year Period - GlobeNewswire
globenewswire.com - May 6 at 6:04 PM
Fluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year PeriodFluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year Period
finance.yahoo.com - May 6 at 6:04 PM
Data Published in Nature Communications Demonstrate the Power of Fluidigm’s CyTOF and Imaging Mass Cytometry Technologies to Transform Cancer Drug Discovery and Enable New Precision Medicine Approaches in Clinical Oncology - Yahoo FinanceData Published in Nature Communications Demonstrate the Power of Fluidigm’s CyTOF and Imaging Mass Cytometry Technologies to Transform Cancer Drug Discovery and Enable New Precision Medicine Approaches in Clinical Oncology - Yahoo Finance
finance.yahoo.com - May 6 at 1:03 PM
Data Published in Nature Communications Demonstrate the Power of Fluidigm’s CyTOF and Imaging Mass Cytometry Technologies to Transform Cancer Drug Discovery and Enable New Precision Medicine Approaches in Clinical OncologyData Published in Nature Communications Demonstrate the Power of Fluidigm’s CyTOF and Imaging Mass Cytometry Technologies to Transform Cancer Drug Discovery and Enable New Precision Medicine Approaches in Clinical Oncology
finance.yahoo.com - May 6 at 1:03 PM
Spring Cleaning Of My Investing Wheelhouse - Seeking AlphaSpring Cleaning Of My Investing Wheelhouse - Seeking Alpha
seekingalpha.com - April 30 at 10:32 AM
Is Fluidigm (NASDAQ:FLDM) Using Debt In A Risky Way? - NasdaqIs Fluidigm (NASDAQ:FLDM) Using Debt In A Risky Way? - Nasdaq
nasdaq.com - April 16 at 6:33 PM
How Many Fluidigm Corporation (NASDAQ:FLDM) Shares Do Institutions Own? - Yahoo FinanceHow Many Fluidigm Corporation (NASDAQ:FLDM) Shares Do Institutions Own? - Yahoo Finance
finance.yahoo.com - April 16 at 1:33 PM
How Many Fluidigm Corporation (NASDAQ:FLDM) Shares Do Institutions Own?How Many Fluidigm Corporation (NASDAQ:FLDM) Shares Do Institutions Own?
finance.yahoo.com - April 16 at 1:33 PM
Genomic Vision appoints Mark David Lynch as Global Commercial and Marketing Director - StreetInsider.comGenomic Vision appoints Mark David Lynch as Global Commercial and Marketing Director - StreetInsider.com
streetinsider.com - April 14 at 7:53 PM
Genomic Vision appoints Mark David Lynch as Global Commercial and Marketing Director - Business WireGenomic Vision appoints Mark David Lynch as Global Commercial and Marketing Director - Business Wire
businesswire.com - April 14 at 2:52 PM
RNA Transcriptomics Market Size to Reach USD 12.46 Billion in 2028 | Increasing Demand for Precision Medicines And Growing Investment are Major Factors Fueling Industry Growth, says Emergen Research - Yahoo FinanceRNA Transcriptomics Market Size to Reach USD 12.46 Billion in 2028 | Increasing Demand for Precision Medicines And Growing Investment are Major Factors Fueling Industry Growth, says Emergen Research - Yahoo Finance
finance.yahoo.com - April 12 at 7:04 PM
Fluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial Results - GlobeNewswireFluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial Results - GlobeNewswire
globenewswire.com - April 8 at 9:05 AM
Fluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial ResultsFluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial Results
finance.yahoo.com - April 8 at 9:05 AM
FLDM Apr 2021 5.000 callFLDM Apr 2021 5.000 call
au.finance.yahoo.com - March 22 at 11:58 PM
3 Extraordinary Diagnostics Stocks for 2021 - Motley Fool3 Extraordinary Diagnostics Stocks for 2021 - Motley Fool
fool.com - March 21 at 1:57 PM
Fluidigm Gets EUA Nod For Home Sample Collection Kit For Advanta COVID-19 AssayFluidigm Gets EUA Nod For Home Sample Collection Kit For Advanta COVID-19 Assay
markets.businessinsider.com - March 3 at 6:42 PM
Fluidigm wins emergency use nod for Advanta SARS-CoV test - Seeking AlphaFluidigm wins emergency use nod for Advanta SARS-CoV test - Seeking Alpha
seekingalpha.com - March 1 at 6:39 PM
Fluidigm Gets EUA Nod For Home Sample Collection Kit For Advanta COVID-19 Assay - BenzingaFluidigm Gets EUA Nod For Home Sample Collection Kit For Advanta COVID-19 Assay - Benzinga
benzinga.com - March 1 at 1:38 PM
FDA Grants Emergency Use Authorization for Home Collection Kit for Advanta Dx SARS-CoV-2 RT-PCR Assay - GlobeNewswireFDA Grants Emergency Use Authorization for Home Collection Kit for Advanta Dx SARS-CoV-2 RT-PCR Assay - GlobeNewswire
globenewswire.com - March 1 at 8:37 AM
This page was last updated on 7/28/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.